GI Cancer Institute

Australia has one of the highest rates of bowel /Colorectal cancer (CRC) in the world. Research has shown that many bowel cancer survivors experience ongoing bowel problems often associated with depression, poorer physical health and distress. Curtin University are undertaking research looking at physical, psychological and social adjustments made by people … Read More

Our CEO Russell Conley and Chair of our Consumer Advisory Committee, Jan Mumford, attended the Rare Cancer Australia’s CanForum conference in Canberra this week. This important forum brought together key leaders in cancer research, treatment and policy, to deliver real solutions for improving the lives of rare cancer patients in … Read More

GI Cancer Institute funded clinical trials are focused on bringing real benefit to real people — including immediate benefit for the people who take part. Since 1991, our trials have helped save and extend lives, and improve the quality of life for people with GI cancers. Among other achievements, our clinical trials have … Read More

We are pleased to be able to promote our latest National Neuroendocrine Carcinoma (NEC) clinical trial – ‘NABNEC’, lead by the GI Cancer Institute’s Principal Investigator,  Dr Mustafa Khasraw. This clinical trial aims to establish the best treatment for this very rare disease by comparing two chemotherapy regiments – nab-paclitaxel … Read More

On Sunday Dr. Lorraine Chantrill, a Board Member of the GI Cancer Institute and oncologist specialising in pancreatic cancer, will be embarking on her 80km trek of the Larapinta Trail in the Northern Territory as part of our Gutsy Challenge adventure. Her motivation for setting herself this challenge is personal. … Read More